These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16613023)

  • 1. Clinicopathological changes and effect of imidocarb therapy in dogs experimentally infected with Babesia canis.
    Máthé A; Vörös K; Németh T; Biksi I; Hetyey C; Manczur F; Tekes L
    Acta Vet Hung; 2006 Mar; 54(1):19-33. PubMed ID: 16613023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene.
    Penzhorn BL; Lewis BD; de Waal DT; López Rebollar LM
    J S Afr Vet Assoc; 1995 Sep; 66(3):157-9. PubMed ID: 8596187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological and ultrastructural studies of renal lesions in Babesia canis infected dogs treated with imidocarb.
    Máthé A; Dobos-Kovács M; Vörös K
    Acta Vet Hung; 2007 Dec; 55(4):511-23. PubMed ID: 18277710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of canine babesiosis in Hungary (63 cases).
    Máthé A; Vörös K; Papp L; Reiczigel J
    Acta Vet Hung; 2006 Sep; 54(3):367-85. PubMed ID: 17020140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in selected subpopulations of lymphocytes in dogs infected with Babesia canis treated with imidocarb.
    Adaszek Ł; Jarosz Ł; Kalinowski M; Staniec M; Grądzki Z; Salmons B; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2015; 43(2):94-100. PubMed ID: 25771779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate.
    Brandão LP; Hagiwara MK; Myiashiro SI
    Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual form of canine babesiosis.
    Van de Maele I; Savary-Bataille K; Gielen I; Daminet S
    Can Vet J; 2008 Mar; 49(3):283-6. PubMed ID: 18390102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical course of babesiosis in 76 dogs infected with protozoan parasites Babesia canis canis.
    Adaszek Ł; Winiarczyk S; Skrzypczak M
    Pol J Vet Sci; 2009; 12(1):81-7. PubMed ID: 19459444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state.
    Holman PJ; Backlund BB; Wilcox AL; Stone R; Stricklin AL; Bardin KE
    J Am Vet Med Assoc; 2009 Oct; 235(7):851-4. PubMed ID: 19793016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First case of babesiosis caused by Babesia canis canis in a dog from Norway.
    Øines Ø; Storli K; Brun-Hansen H
    Vet Parasitol; 2010 Aug; 171(3-4):350-3. PubMed ID: 20378251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autochthonous babesiosis in dogs in the Netherlands?].
    Houwers DJ; Teske E; Jongejan F
    Tijdschr Diergeneeskd; 2004 May; 129(9):310. PubMed ID: 15156658
    [No Abstract]   [Full Text] [Related]  

  • 13. Canine babesiosis in France.
    Bourdoiseau G
    Vet Parasitol; 2006 May; 138(1-2):118-25. PubMed ID: 16507334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Babesia and the pet travel scheme.
    Perkins SC
    Vet Rec; 2000 Oct; 147(16):460. PubMed ID: 11079446
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence of an acute phase response in dogs naturally infected with Babesia canis.
    Matijatko V; Mrljak V; Kis I; Kucer N; Forsek J; Zivicnjak T; Romić Z; Simec Z; Ceron JJ
    Vet Parasitol; 2007 Mar; 144(3-4):242-50. PubMed ID: 17116368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and molecular characterization of a novel large Babesia species in a dog.
    Birkenheuer AJ; Neel J; Ruslander D; Levy MG; Breitschwerdt EB
    Vet Parasitol; 2004 Oct; 124(3-4):151-60. PubMed ID: 15381295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated imidocarb treatment failure suggesting emerging resistance of Babesia canis in a new endemic area in north-eastern Germany.
    Weingart C; Krücken J; Kohn B
    Ticks Tick Borne Dis; 2024 May; 15(3):102315. PubMed ID: 38301344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microscopic and molecular analysis of Babesia canis in archived and diagnostic specimens reveal the impact of anti-parasitic treatment and postmortem changes on pathogen detection.
    Huber D; Beck A; Anzulović Ž; Jurković D; Polkinghorne A; Baneth G; Beck R
    Parasit Vectors; 2017 Oct; 10(1):495. PubMed ID: 29047398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods.
    Sasanelli M; Paradies P; Greco B; Eyal O; Zaza V; Baneth G
    Vet Parasitol; 2010 Aug; 171(3-4):194-9. PubMed ID: 20444549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
    Kumar S; Gupta AK; Pal Y; Dwivedi SK
    J Vet Med Sci; 2003 Nov; 65(11):1171-7. PubMed ID: 14665744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.